Bionano genomics, inc (BNGO)
Income statement / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17
Revenue:
Total revenue

2,789

3,312

2,174

1,852

4,013

2,828

3,390

1,768

2,743

Cost of revenue:
Total cost of revenue

1,690

2,375

1,555

1,147

2,988

3,068

1,813

841

1,690

Operating expenses:
Research and development

2,399

2,173

2,407

2,100

2,513

2,505

2,098

2,367

2,967

Selling, general and administrative

5,859

4,449

5,056

4,790

4,610

3,224

3,489

2,895

3,116

Total operating expenses

8,258

6,622

7,463

6,890

7,123

5,729

5,588

5,262

6,083

Loss from operations

-7,160

-5,685

-6,844

-6,185

-6,098

-5,968

-4,012

-4,335

-5,031

Other income (expense)
Interest expense

869

578

565

272

266

404

407

301

145

Fair Value Adjustment of Warrants

0

0

0

0

-0

-1,520

-1,517

-953

-154

Gain (Loss) on Extinguishment of Debt

-412

0

0

-921

0

0

-342

0

-

Other expenses

-549

130

249

468

36

75

61

159

68

Total other income (expenses)

-732

-708

-815

-1,662

-303

1,039

706

491

-59

Loss before income taxes

-7,893

-6,393

-7,660

-7,847

-6,402

-4,929

-3,305

-3,843

-5,090

Income Tax Expense (Benefit)

7

4

4

4

9

-2

5

3

-4

Net loss

-7,900

-6,398

-7,664

-7,851

-6,411

-4,926

-3,311

-3,847

-5,085

Net loss per share, basic and diluted (USD per share)

0.08

-0.59

-0.71

-0.77

0.16

-0.63

-0.98

-1.16

-1.74

Weighted-average common shares outstanding basic and diluted (shares)

27,943

10,897

10,860

10,210

13,850

7,778

3,364

3,315

2,920

Product revenue
Total revenue

2,604

3,162

2,020

1,687

3,844

2,700

3,256

1,662

-

Total cost of revenue

1,612

2,237

1,525

1,119

2,853

3,064

1,803

840

-

Service and other revenue
Total revenue

184

150

154

165

168

128

133

106

-

Total cost of revenue

77

137

29

27

134

3

9

0

-